Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Neurovascular Embolization Devices Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The neurovascular embolization devices market size has experienced robust growth in recent years. This market is projected to expand from $1.38 billion in 2025 to $1.47 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. Historically, this growth has been fueled by factors such as the increasing occurrence of cerebral aneurysms, the widening scope of neurointerventional procedures, the greater accessibility of expert neurovascular specialists, increasing hospital expenditures on advanced neurocare, and the broader acceptance of minimally invasive stroke treatments.
The neurovascular embolization devices market is projected to experience substantial expansion over the coming years. This market is set to reach a valuation of $1.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This anticipated growth is driven by several factors, including the escalating demand for sophisticated stroke management solutions, increased investments in neurovascular research and development, the expanding elderly demographic affected by vascular disorders, the rising acceptance of advanced embolization devices, and a greater emphasis on enhancing procedural results. Key developments shaping this period encompass the wider embrace of flow diversion stents, the growing application of liquid embolic systems, a preference for minimally invasive neurointerventions, the evolution of coil technologies with advanced coatings, and a heightened focus on precise neurovascular instruments.
Get A Free Sample Report With In-Depth Market Insights:
Neurovascular Embolization Devices Market Expansion Drivers: What’s Shaping Future Growth?
An anticipated increase in the occurrence of hemorrhages is projected to drive the neurovascular embolization devices market in the future. Hemorrhages refer to atypical, uncontrolled bleeding episodes, manifesting either internally within the body or externally through a rupture in the skin or mucous membrane. Various elements contribute to the commonality of hemorrhages, including an aging demographic, a heightened rate of hypertension, and broader application of anticoagulant drugs. These neurovascular embolization devices find application in hemorrhagic strokes, where they serve to block irregular blood vessels, thereby diminishing bleeding and averting additional brain harm. As an illustration, research from King’s College London, a public research university located in the UK, indicated in February 2024 that a 59.4% rise in the incidence and fatalities from intracerebral hemorrhage (ICH), a particular kind of hemorrhage, is anticipated among individuals aged 70 to 95 throughout the UK by the year 2050. Consequently, the growing frequency of hemorrhages is a key factor stimulating expansion in the neurovascular embolization devices market.
Neurovascular Embolization Devices Market Breakdown By Product Type And Application
The neurovascular embolization devices market covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Neurovascular Hemorrhage Management, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: N-Butyl Cyanoacrylate-Based Embolics, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters
Neurovascular Embolization Devices Market Strategic Trends: What Defines The Next Growth Phase?
Major companies within the neurovascular embolization devices market are concentrating on developing advanced solutions, such as next-generation flow diverters, intended to supersede traditional aneurysm treatment methods. A next-generation flow diverter is characterized as a device that improves procedural safety and efficacy by enhancing vessel wall apposition, reducing the likelihood of clotting, and enabling simpler deployment in complex aneurysm anatomies. For instance, in July 2025, Stryker Corporation, a US-based medical technology company, launched the Surpass Elite Flow Diverter into its neurovascular portfolio. This innovation replaces older aneurysm treatment devices by providing minimally invasive flow diversion therapy for large or giant unruptured intracranial aneurysms. It delivers improved thrombo-resistance and an optimized braid design, allowing physicians to achieve better procedural outcomes with less manipulation. Integrated with Stryker’s training and physician support programs, it ensures a seamless clinical experience. The Surpass Elite Flow Diverter enhances patient safety, simplifies procedural workflow, and helps expand the adoption of flow diversion therapy in neurovascular care.
Neurovascular Embolization Devices Market Competitive Overview And Top Companies
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc
View The Full Neurovascular Embolization Devices Market Report:
Neurovascular Embolization Devices Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
